| 1 | 91468 | N-Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis. | Clin Pharmacol Ther | 1979 Nov |
3 |
| 2 | 237647 | Polymorphic acetylation procainamide in man. | Clin Pharmacol Ther | 1975 Jun |
2 |
| 3 | 322922 | Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions. | Clin Pharmacol Ther | 1977 May |
1 |
| 4 | 776488 | Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions. | Clin Pharmacol Ther | 1976 May |
2 |
| 5 | 872496 | Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function. | Clin Pharmacol Ther | 1977 Jul |
7 |
| 6 | 975731 | Hemodialysis for severe procainamide toxicity: clinical and pharmacokinetic observations. | Clin Pharmacol Ther | 1976 Nov |
2 |
| 7 | 1122675 | Antiarrhythmic potency of N-acetylprocainamide. | Clin Pharmacol Ther | 1975 Feb |
1 |
| 8 | 1263131 | Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog. | J Pharmacol Exp Ther | 1976 Apr |
2 |
| 9 | 1384320 | Combined high-efficiency hemodialysis and charcoal hemoperfusion in severe N-acetylprocainamide intoxication. | Am J Kidney Dis | 1992 Oct |
2 |
| 10 | 2410877 | Torsades de pointes due to n-acetylprocainamide. | Pacing Clin Electrophysiol | 1985 Jul |
3 |
| 11 | 2424305 | Procainamide toxicity in a patient with acute renal failure. | Am J Kidney Dis | 1986 Jun |
1 |
| 12 | 2431875 | Effects of cortical lesions on middle-latency auditory evoked responses (MLR). | Electroencephalogr Clin Neurophysiol | 1987 Feb |
1 |
| 13 | 2433967 | Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide. | Angiology | 1986 Dec |
1 |
| 14 | 2433970 | Pharmacokinetics of N-acetylprocainamide. | Angiology | 1986 Dec |
6 |
| 15 | 2433971 | Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus. | Angiology | 1986 Dec |
2 |
| 16 | 2436466 | Effects of intravenous N-acetylprocainamide on hemodynamics and left ventricular function in man. | Am Heart J | 1987 Apr |
3 |
| 17 | 2439251 | Effect kinetics of N-acetylprocainamide-induced QT interval prolongation. | Clin Pharmacol Ther | 1987 Jul |
1 |
| 18 | 2443639 | Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites. | J Pharm Sci | 1987 May |
1 |
| 19 | 2447406 | Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships. | J Cardiovasc Pharmacol | 1987 Nov |
1 |
| 20 | 2457345 | Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide. | Angiology | 1988 Jul |
1 |
| 21 | 2457560 | Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis. | Int J Clin Pharmacol Ther Toxicol | 1988 Feb |
1 |
| 22 | 2458879 | Trimethoprim alters the disposition of procainamide and N-acetylprocainamide. | Clin Pharmacol Ther | 1988 Oct |
7 |
| 23 | 2467982 | Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated. | J Pharmacol Exp Ther | 1989 Mar |
3 |
| 24 | 2474402 | Pharmacokinetics of N-acetylprocainamide in patients profiled with a stable isotope method. | Clin Pharmacol Ther | 1989 Aug |
3 |
| 25 | 3368667 | Clinico-experimental studies on auditory evoked middle latency response (AEMLR) with specific reference to generation and auditory dominancy. | J UOEH | 1988 Mar 1 |
2 |
| 26 | 6084435 | Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias. | Ann N Y Acad Sci | 1984 |
1 |
| 27 | 6156049 | Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease. | Clin Pharmacol Ther | 1980 Jul |
1 |
| 28 | 6158263 | Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. | Am J Cardiol | 1980 Sep |
1 |
| 29 | 6160014 | Kinetics of N-acetylprocainamide deacetylation. | Clin Pharmacol Ther | 1980 Nov |
3 |
| 30 | 6161089 | Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects. | Int J Clin Pharmacol Ther Toxicol | 1980 Jun |
1 |
| 31 | 6179685 | N-Acetylprocainamide kinetics and clinical response during repeated dosing. | Clin Pharmacol Ther | 1982 Sep |
1 |
| 32 | 6188570 | Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias. | Clin Pharmacol Ther | 1983 May |
1 |
| 33 | 6189384 | Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias. | Am Heart J | 1983 May |
3 |
| 34 | 6198178 | Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide. | Eur J Clin Pharmacol | 1983 |
1 |
| 35 | 6201304 | Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method. | Clin Chem | 1984 May |
1 |
| 36 | 6204527 | Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case. | Am J Kidney Dis | 1984 Jul |
2 |
| 37 | 6206104 | Torsade de pointes induced by N-acetylprocainamide. | J Am Coll Cardiol | 1984 Sep |
3 |
| 38 | 6261406 | Procainamide and peripheral neuropathy. | South Med J | 1981 Apr |
2 |
| 39 | 7501022 | A possible docking and fusion particle for synaptic transmission. | Nature | 1995 Dec 14 |
1 |
| 40 | 7525982 | The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration. | J Vet Pharmacol Ther | 1994 Aug |
3 |
| 41 | 7622514 | The N-ethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin. | J Biol Chem | 1995 Jul 14 |
1 |
| 42 | 7657692 | Distinct effects of alpha-SNAP, 14-3-3 proteins, and calmodulin on priming and triggering of regulated exocytosis. | J Cell Biol | 1995 Sep |
1 |
| 43 | 7835334 | A role for soluble NSF attachment proteins (SNAPs) in regulated exocytosis in adrenal chromaffin cells. | EMBO J | 1995 Jan 16 |
3 |
| 44 | 8221884 | A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. | Cell | 1993 Nov 5 |
1 |
| 45 | 8477118 | Possible case of procainamide-induced intrahepatic cholestatic jaundice. | Ann Pharmacother | 1993 Apr |
2 |
| 46 | 8604041 | Localization of synaptotagmin-binding domains on syntaxin. | J Neurosci | 1996 Mar 15 |
1 |
| 47 | 8671917 | Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity. | Nephrol Dial Transplant | 1996 May |
1 |
| 48 | 8744944 | Domains of alpha-SNAP required for the stimulation of exocytosis and for N-ethylmalemide-sensitive fusion protein (NSF) binding and activation. | Mol Biol Cell | 1996 May |
3 |
| 49 | 8786250 | Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans. | J Clin Pharmacol | 1995 Sep |
13 |
| 50 | 8844445 | Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarization. | J Clin Pharmacol | 1996 Jul |
5 |